Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1116

Nov 5, 2021

Can Artificial Intelligence Save America From The Global Supply Chain Disaster?

Posted by in categories: biotech/medical, food, robotics/AI

The issue facing the world today is not simply “THE supply chain,” the issue is that nearly every single link in the supply chain is compromised. Human talent is less available and manufacturers fear this will become a permanent reality, even after the pandemic. Extreme weather events occur every month and the ongoing pandemic is also causing shortages of direct and indirect materials. In turn, shipping costs have risen sharply. The status of sheet metal, computer chips and all food ingredients are up in the air. Constraints on the supply of raw materials, including those needed for semiconductors, PPE and various plastics, have led to factory shutdowns. A chronic lack of truck drivers has every neighborhood filled empty store shelves staring back at its citizens. And, to no surprise, Inflation was just reported at 5.4%, which is a 13 year high.

Now consider that only 4% of supply chain leaders believe their operations are future ready. We are at the precipice of either complete disaster, or a brave new world.

Nov 5, 2021

New way to infiltrate hard-to-treat cancers

Posted by in category: biotech/medical

Scientists have found a way to deactivate DDR1, a molecule that forms a barrier ‘like barbed wire’ in tumours. By removing this barrier, anti-tumour immune cells could target aggressive forms of breast cancer.

Nov 5, 2021

Scientists Discover a Novel Therapeutic Target To Treat Fatty Liver Disease

Posted by in category: biotech/medical

About 80 million Americans have fatty liver disease unrelated to alcohol abuse. Nonalcoholic fatty liver disease is associated with obesity and diabetes, and can lead to more severe liver damage such as nonalcoholic steatohepatitis (NASH), cirrhosis and liver cancer. Cardiovascular disease, colorectal cancer and breast cancer actually are the major causes of death in patients with fatty liver disease.

Several drugs in advanced stages of development have failed because of the complexity of the disease, low efficacy, or the toxicity of drugs. Although several clinical trials were conducted in past decades, currently there is no FDA-approved pharmaceutical therapy for NASH.

To understand the complexity of the progression of fatty liver disease, a team of USC.

Nov 5, 2021

Plans Of A Technocratic Elite: ‘The Great Reset’ Is Not A Conspiracy Theory

Posted by in categories: 3D printing, biotech/medical, genetics, information science, internet, nanotechnology, quantum physics, Ray Kurzweil, robotics/AI, singularity, transhumanism

According to Klaus Schwab, the founder and executive chair of the World Economic Forum (WEF), the 4-IR follows the first, second, and third Industrial Revolutions—the mechanical, electrical, and digital, respectively. The 4-IR builds on the digital revolution, but Schwab sees the 4-IR as an exponential takeoff and convergence of existing and emerging fields, including Big Data; artificial intelligence; machine learning; quantum computing; and genetics, nanotechnology, and robotics. The consequence is the merging of the physical, digital, and biological worlds. The blurring of these categories ultimately challenges the very ontologies by which we understand ourselves and the world, including “what it means to be human.”

The specific applications that make up the 4-R are too numerous and sundry to treat in full, but they include a ubiquitous internet, the internet of things, the internet of bodies, autonomous vehicles, smart cities, 3D printing, nanotechnology, biotechnology, materials science, energy storage, and more.

While Schwab and the WEF promote a particular vision for the 4-IR, the developments he announces are not his brainchildren, and there is nothing original about his formulations. Transhumanists and Singularitarians (or prophets of the technological singularity), such as Ray Kurzweil and many others, forecasted these and more revolutionary developments,. long before Schwab heralded them. The significance of Schwab and the WEF’s take on the new technological revolution is the attempt to harness it to a particular end, presumably “a fairer, greener future.”

Nov 5, 2021

Physicists Discover How DNA Molecules Self-Assemble: Laws of Nature Harnessed To Create “Smart Materials”

Posted by in categories: biotech/medical, genetics

A team of physicists has discovered how DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Nov 5, 2021

A SRI report from IAC2021, 72nd International Astronautical Congress at Dubai

Posted by in categories: biotech/medical, business, government, space

SRI Newsletter, a report from IAC2021 Dubaiby Prof. Bernard Foing, SRI President, and.


Paramount important too, space philosophy and humanities are now well recognized and accepted by the space community. The first IAF Congress I attended, 1998 at Melbourne, was dramatically void of philosophy, yet participants already were missing it. I saw many young people at IAC2021, scientists, designers, economists, scholars of various disciplines, including philosophy. And, heartwarming indeed, Space Renaissance had a great enthusiastic welcome. The space people know us (and know me!), many people which I didn’t know personally shook my hand, asked me for comments and short talks, were enthusiast about the Space Renaissance… All of that is for sure due to the big work we made for our recent congress, and of course to the great world-wide influence of our new President, Prof. Bernard Foing. Yet, there is something deeper, in the feeling of this peculiar sub-assembly of humankind, that was looking ahead enough to dedicate their life to human expansion into outer space. The last two years – characterized by the Covid pandemics — have worked hard, to shape and forge space leaders, raising the awareness of the urgency to kick-off the civilian space development. And it is now maybe a general acknowledge that the space philosophers were right, when they were rushing for an acceleration of the enabling technologies, low cost access to space, space tourism, space safety, … The need to get rid of space debris was well present in several speeches, even if only a few dare to target space debris as a huge source of business development, when we’ll start capturing and reusing them.

Nov 5, 2021

Sponges don’t have brains. But they might have an echo of them where they eat

Posted by in categories: biotech/medical, neuroscience

Simple sponges contain cells that appear to send signals to digestive chambers, a communication system that offer hints about how brains evolved.

Nov 4, 2021

We Have Always Been Cyborgs: Professor Stefan Lorenz Sorgner — John Cabot University

Posted by in categories: bioengineering, biotech/medical, cyborgs, life extension, transhumanism

Professor Stefan Lorenz Sorgner talks about his new book, ‘We Have Always Been Cyborgs’. Find out more about the book: https://bristoluniversitypress.co.uk/we-have-always-been-cyborgs.

“With an encyclopaedic knowledge of transhumanism and a deep philosophical grounding, especially in Nietzschean thought, Stefan Sorgner tackles some of the most challenging ethical issues currently discussed, including gene editing, digital data collection, and life extension, with uncommon good sense and incisive conclusions. This study is one of the most detailed and comprehensive analyses available today. Highly recommended for anyone interested in transhumanist/posthumanist ideas and in these issues generally.” N. Katherine Hayles, University of California, Los Angeles.

Continue reading “We Have Always Been Cyborgs: Professor Stefan Lorenz Sorgner — John Cabot University” »

Nov 4, 2021

A system to control robotic arms based on augmented reality and a brain-computer interface

Posted by in categories: augmented reality, bioengineering, biotech/medical, cyborgs, robotics/AI, transhumanism

For people with motor impairments or physical disabilities, completing daily tasks and house chores can be incredibly challenging. Recent advancements in robotics, such as brain-controlled robotic limbs, have the potential to significantly improve their quality of life.

Researchers at Hebei University of Technology and other institutes in China have developed an innovative system for controlling robotic arms that is based on augmented reality (AR) and a . This system, presented in a paper published in the Journal of Neural Engineering, could enable the development of bionic or prosthetic arms that are easier for users to control.

“In recent years, with the development of robotic arms, brain science and information decoding technology, brain-controlled robotic arms have attained increasing achievements,” Zhiguo Luo, one of the researchers who carried out the study, told TechXplore. “However, disadvantages like poor flexibility restrict their widespread application. We aim to promote the lightweight and practicality of brain-controlled robotic arms.”

Nov 4, 2021

Blog: I believe we are on the cusp of an incredible new era of biological and medical research

Posted by in categories: biotech/medical, robotics/AI

Last year DeepMind’s breakthrough AI system AlphaFold2 was recognised as a solution to the 50-year-old grand challenge of protein folding, capable of predicting the 3D structure of a protein directly from its amino acid sequence to atomic-level accuracy. This has been a watershed moment for computational and AI methods for biology.

Building on this advance, today, I’m thrilled to announce the creation of a new Alphabet company – Isomorphic Labs – a commercial venture with the mission to reimagine the entire drug discovery process from the ground up with an AI-first approach and, ultimately, to model and understand some of the fundamental mechanisms of life.

For over a decade DeepMind has been in the vanguard of advancing the state-of-the-art in AI, often using games as a proving ground for developing general purpose learning systems, like AlphaGo, our program that beat the world champion at the complex game of Go. We are at an exciting moment in history now where these techniques and methods are becoming powerful and sophisticated enough to be applied to real-world problems including scientific discovery itself. One of the most important applications of AI that I can think of is in the field of biological and medical research, and it is an area I have been passionate about addressing for many years. Now the time is right to push this forward at pace, and with the dedicated focus and resources that Isomorphic Labs will bring.